Medanta files FY25-26 Annual Report, AGM on Sep 16
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts less than Nifty Midcap 150 and 0.1 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Medanta filed its FY25-26 Annual Report, BRSR and AGM Notice. The 22nd AGM will be held on September 16, 2026 via video conferencing. Statutory auditor Walker Chandiok gave an unqualified opinion. Key FY26 numbers: consolidated income rose 19.6% to Rs 45,089 million, PAT up 15.1% to Rs 5,541 million. 623 new beds added. Board recommends Rs 0.50 per share dividend.
Strong growth with dividend, capacity expansion and clean auditor report. Positive signals for shareholders.